Exploring how children of diabetic parents carry invisible metabolic signatures that alter their bodies' sugar processing, fat storage, and inflammation responses.
Exploring why ACE inhibitors show different effectiveness in Japanese heart attack patients compared to Western populations.
Exploring how in-silico methods are transforming antileishmanial drug discovery through computational approaches like molecular docking and AI-driven target identification.